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Introduction
In 2018, an estimated 572,000 oesophageal cancer cases 
and 509,000 deaths occurred worldwide [1]. In Switzer-
land, approximately 600 newly diagnosed cases and 460 
oesophageal cancer deaths occur each year [2]. Owing to its 
high lethality, oesophageal cancer has a substantial public 
health impact in Switzerland and across the world [3, 4].
The main histological types of oesophageal cancer are ad-
enocarcinoma and squamous cell carcinoma. Studies in 
developed countries have reported substantial rises in the 
incidence of adenocarcinoma of the oesophagus accompa-
nied by stabilizing or falling rates of oesophageal squa-
mous cell carcinoma [5, 6]. In the US, the incidence of 
oesophageal adenocarcinoma rose rapidly since the mid-
1970s especially among white males, surpassing oesopha-
geal squamous cell carcinoma around the year 1990 [7]. 
Comparable trends have been observed in several Europe-
an countries [5, 6]. However, there is substantial variation 
in both incidence rates and trends between countries and 
regions most likely driven by differences in risk factors [8]. 
Adenocarcinoma and squamous cell carcinoma have quite 
different aetiologies. The key risk factors for oesophageal 
adenocarcinoma are obesity and gastro-oesophageal reflux 
disease (GORD) [8],whereas squamous cell carcinomas are 
The rising incidence of oesophageal 
adenocarcinoma in Switzerland 
Anita Feller 1, Francesco Galli 1, Sabine Rohrmann2,3, and the NICER Working Group* 
1 Foundation National Institute for Cancer Epidemiology and Registration (NICER), Zürich
2 Cancer Registry Zürich and Zug, Zürich
3 Epidemiology, Biostatistics, and Prevention Institute, Zürich
*Composition of the NICER Working Group individual contributors is listed alphabetically in acknowledgments.
mainly related to heavy alcohol consumption, smoking 
and their synergistic effects [8].   
A previous Swiss study covering the period 1982-2011 
reported on incidence trends of histological subtypes of 
oesophageal cancer stratified by language region [9]. How-
ever, data for the whole of Switzerland is lacking so far. 
Therefore, this study evaluated trends in the incidence 
of oesophageal cancer for both major histologic types in 
Switzerland using nationally representative data over a 
30-year period.
Methods
Data Sources 
Data on primary oesophageal cancer cases were extract-
ed from the National Cancer Database managed by the 
Foundation National Institute for Cancer Epidemiology 
and Registration (NICER). Population-based cantonal 
and regional cancer registries collect data directly from 
the patients’ medical records and transmit a defined and 
pseudonymised subset of the data to NICER. The defini-
tion of primary cancers followed the rules as defined by the 
International Association of Cancer Registries (IACR) and 
International Association for Research on Cancer (IARC) 
[10]. The proportion of death certificate only (%DCO) 
cases and morphologically verified cases (%MV) was 1.7% 
and 97.3%, respectively. Due to the gradual introduction 
of cancer registration in Switzerland, population coverage 
varied from 47.3% in 1986 to 88.3% in 2015.
Cantonal mid-year population estimates for all persons 
with permanent residence status within each canton were 
provided by the Swiss Federal Statistical Office.
Classification by histology
Histological categories were classified as: (1) adenocarci-
noma (ICD-O-3: M814-M857), (2) squamous cell carcino-
ma (ICD-O-3: M8050-M8082), (3) other subtypes/NOS 
(ICD-O-3: M800-M804, M809-M813, M858-M994). 
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Analytical methods
To assess time trends, annual and 5-year age-standardized 
incidence rates (ASIR) (direct method, European standard 
[11]) per 100,000 person-years (PY) were calculated using 
mid-year population estimates for each canton. Propor-
tions of histological types were calculated based on mor-
phologically confirmed cases. To account for variations in 
the population coverage of the linguistic regions, we used 
weights according to the population share (pop
linguistic region
 / 
pop
Switzerland
 per age group, sex and calendar year).
Estimated annual percentage changes (EAPC) with nine-
ty-five percent confidence intervals (95%CI) were ob-
tained by fitting linear regression models using the natu-
ral log of annual ASIRs as target variable and the year of 
incidence as predictor. 
Results
Between 1986 and 2015, 9,481 oesophageal cancer cases 
were diagnosed in the study population (Tab. 1). Oe-
sophageal cancer was much more frequent in males than 
in females resulting in a male-to-female ratio of approxi-
mately 3:1. Overall, ASIR of oesophageal cancer slightly 
increased up to 2001-2005, and stabilised afterwards 
resulting in an ASIR of 8.3 [95%CI 7.9;8.7] and 2.2 
[95%CI 2.0;2.4] per 100,000 PY in 2011-2015 in males 
and females, respectively.
Between 1986-1990 and 2011-2015, ASIR of oesopha-
geal adenocarcinoma increased significantly in both 
sexes from 1.4 [95%CI 1.2; 1.7] per 100,000 PY to 4.4 
[95%CI 4.1; 4.7] per 100,000 PY in males, and from 0.3 
[95%CI 0.2; 0.5] per 100,000 PY to 0.7 [95%CI 0.6; 
0.8] per 100,000 PY in females (Fig. 1). The increase was 
slightly steeper in males (EAPC 4.7 [95%CI 3.8; 5.6], 
p<0.001) compared to females (EAPC 4.5, [95%CI 2.8; 
6.3], p<0.001) (Tab. 1). 
In contrast, incidence of oesophageal squamous cell car-
cinoma decreased significantly in males by around 1.9% 
([95%CI -2.4; -1.4], p<0.001) per year, but remained 
stable in females (EAPC 0.1, [95%CI -0.6; 0.8], p>0.05). 
Squamous cell carcinoma was the predominant histologic 
type during the study period in females. In males, the pro-
portion of oesophageal adenocarcinoma rose substantially 
from 1986 to 2015 and became the predominant histo-
logic type in males surpassing squamous cell carcinoma in 
2006-2010 with a proportion of 50.8% (Fig. 2).
Discussion
In the present study, a considerable increase in the oc-
currence of oesophageal adenocarcinoma was observed in 
Switzerland, reflecting similar trends in other developed 
countries [5, 6]. Around the year 2006, oesophageal ad-
enocarcinoma became the predominant histology in the 
male population, which was previously mainly affected by 
oesophageal squamous cell carcinoma.
The strong association of tobacco smoking and alcohol 
consumption with oesophageal squamous cell carcinoma 
is well documented. In developed countries, these two risk 
factors account for the biggest proportion of all observed 
cases (8). In Switzerland, as in other countries in Eu-
rope, frequency of smoking-related malignancies [12] and 
smoking prevalence among males are steadily decreasing 
[13]. Moreover, alcohol consumption in Switzerland has 
significantly declined during the last 30 years [14], par-
ticularly among men [13]. The important decline in squa-
mous cell carcinoma of the oesophagus in men observed in 
our study is most likely driven by the falling prevalence of 
smoking and alcohol consumption. Our results, however, 
do not show an increasing trend of oesophageal squamous 
cell carcinoma among Swiss women, despite the rise in 
smoking prevalence followed in more recent years by a 
significant increase in both incidence (+50%) and mortal-
ity (50%) of lung cancer (1983-1987 to 2008-2012) [12]. 
N EAPC 95% CI p-value
Males
   Adenocarcinoma
   Squamous cell carcinoma
   Others/NOS
   Total
2,617
3,956
515
7,088
4.7 
-1.9
-1.1
0.4
[3.8; 5.6]
[-2.4; -1.4]
[-2.5; 0.2]
[-0.1; 0.8]
<0.001
<0.001
0.089
0.085
Females
   Adenocarcinoma
   Squamous cell carcinoma
   Others/NOS
   Total
585
1.588
220
2,393
4.5
0.1
-1.1
0.9
[2.8; 6.3]
[-0.6; 0.8]
[-3.1; 1.2]
[0.3; 1.5]
<0.001
0.719
0.337
<0.01
Tab. 1. 
Estimated annual 
percentage change for 
oesophageal cancer by 
sex and histology from 
1986 to 2015.
Others/NOS: other 
histologic subtype/not 
otherwise specified.
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Fig. 1.  Time trends in age-standardised incidence rates (European standard population) of oesophageal cancer by sex, 
histological type, Switzerland 1986-2015. Others/NOS: other histologic subtype/not otherwise specified.
Fig. 2.  Time trends in proportions of oesophageal cancer cases by sex, histologic type, Switzerland 1986-2015. 
Others/NOS: other histologic subtype/not otherwise specified.
   Schweizer Krebsbulletin  Nr. 2/2019 163
NICER
Interestingly, a previous Swiss study reported diverging 
trends in females depending on linguistic region of resi-
dence (significantly increasing incidence of oesophageal 
squamous cell carcinoma in the German-speaking region, 
stable incidence in the French-Italian-speaking region of 
Switzerland) [9]. The same study reported lower rates of 
oesophageal squamous cell carcinoma in males living in 
the German-speaking region compared to males living 
in the French-Italian-speaking region of Switzerland, but 
similar annual percentage decreases [9].
Tobacco smoking is also associated, although less strongly, 
with an increased occurrence of oesophageal adenocarci-
noma [15]. As previously mentioned, smoking prevalence 
in Swiss males continues to decline. Therefore, smoking 
seems not to be a major contributing factor for the rising 
incidence of oesophageal adenocarcinoma in Switzerland. 
Factors frequently described as being responsible for the 
rising incidence of oesophageal adenocarcinoma are in-
creasing prevalence of gastro-oesophageal-reflux disease 
(GORD) and obesity, as well as decreasing prevalence of 
Helicobacter pylori infections. A strong association be-
tween GORD-related symptoms and oesophageal adeno-
carcinoma was documented. In a 2010 meta-analysis, a 
5-fold and 7-fold increase in risk of oesophageal adenocar-
cinoma was found among individuals reporting, respec-
tively, weekly or daily GORD symptoms, as compared to 
those with less frequent or no symptoms [16]. In 2004, 
the prevalence of GORD in the Swiss adult population 
was 17.6% [17] and was reported to be more frequent in 
the French-speaking region of Switzerland, but equally 
distributed among sexes. A meta-analysis established an 
association between body mass index (BMI) and oesopha-
geal cancer, with an 11% higher likelihood of oesophageal 
adenocarcinoma occurrence for each 5 kg/m2 increment of 
BMI [18]. The International Association of Research on 
Cancer (IACR) reported a 4.8-fold increased risk of de-
veloping oesophageal adenocarcinoma for people falling 
into the highest BMI category (BMI >=40) compared to 
normal weighted individuals (BMI 18.5-24.9) [19]. More-
over, BMI likely interacts in synergy with GORD [20]. 
In recent years, the proportion of overweight and obese 
individuals has increased, in Switzerland like in other de-
veloped countries. Indeed, between 1992 and 2017, the 
total Swiss overweight population (BMI>=25 kg/m2) rose 
from 30% to 42% and in the obese segment (BMI >=30 
kg/m2) from 5% to 11% [13]. Finally, infection by Heli-
cobacter pylori, a known risk factor for non-cardia gas-
tric cancer, appears to be a protective factor against oe-
sophageal adenocarcinoma. A meta-analysis showed that 
Helicobacter pylori infection confers a nearly 40% lower 
risk of oesophageal adenocarcinoma [21]. Heuberger et al. 
investigated the prevalence of Helicobacter pylori infec-
tion in Swiss adolescents 1999-2002 and found it to be 
one of the lowest in Europe (9.7%) [22]. However, it has 
been questioned whether trends in known risk factors can 
fully explain the rising incidence and the striking pre-
dominance of oesophageal adenocarcinoma in males [23]. 
Strengths and Weaknesses
This is a Swiss population-based investigation on oesoph-
ageal cancer incidence by histological type, which covers 
a long period of 30 years providing the most representa-
tive findings to date. Despite the partial coverage of the 
Swiss population by the included cancer registries, the 
important sample size representing the major linguistic 
regions allows generalizability of our findings to the na-
tional level. Moreover, the low proportion of death certifi-
cate only cases (2%) indicates a high completeness of case 
ascertainment. 
Uncertainty in distinguishing the organ of origin in can-
cers occurring at the gastro-oesophageal junction [24] rep-
resents an important weakness of our study. In order to 
deal with this issue, adenocarcinoma of the oesophagus 
and gastric cardia were combined in the analyses of some 
other studies. This solution was not an option in our case, 
because of the high proportion of cases with unspecified 
anatomical localization. Another limitation of our study 
is the lack of knowledge on prevalence trends in risk and 
protective factors covering the whole study period and 
preceding periods. Finally, our findings may be, at least 
partially, influenced by improvements in endoscopic tech-
nology and an increased standard use of endoscopic proce-
dures resulting in more sensitive detection [25].
Conclusions
A significant increase in the incidence of adenocarcinoma 
of the oesophagus was observed in Switzerland during the 
study period 1986-2015. A parallel rise of GORD and 
obesity over the same period may, at least partially, be re-
sponsible for this trend. For oesophageal squamous cell 
carcinoma, a decreasing trend was only observed in males 
most likely related to sex-specific lifestyle changes.
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